Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Policy Tracker

Full Bill Tracker

Every tracked proposal: pending, failed, superseded, stalled and enacted — across psychedelics, cannabis, kratom and 7-OH.

Czech Republic

Bills tracked for this country and its states or regions.

2 of 2 tracked bills · newest recorded action first

  • 270/2025 Sb.

    Act amending the Criminal Code, the Code of Criminal Procedure and related laws [Zákon, kterým se mění zákon č. 40/2009 Sb., trestní zákoník, ... a další související zákony] (2025)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedJul 3, 2025 (done)
    4. Law in effectJan 1, 2026 (done)

    No dated action recorded

    A wider criminal-law amendment that provides for medical use of psilocybin from 1 January 2026.

    Bill source (opens in a new tab)
  • 552/2025 Sb.

    Government Regulation on conditions for prescribing, dispensing and using individually prepared medicinal products containing psilocybin for medical use [Nařízení vlády o podmínkách pro předepisování, výdej a používání individuálně připravovaných léčivých přípravků s obsahem psilocybinu pro léčebné použití] (2025)

    1. IntroducedDate TBC (done)
    2. PassedDate TBC (done)
    3. SignedDec 10, 2025 (done)
    4. Law in effectJan 1, 2026 (done)

    No dated action recorded

    The government regulation sets conditions for prescribing, dispensing and using individually prepared psilocybin medicines.

    Bill source (opens in a new tab)